Loading clinical trials...
Loading clinical trials...
An Open Label, Randomised, Six-way Crossover, Single Dose Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination
Conditions
Interventions
GSK961081
Fluticasone furoate
Locations
1
Australia
GSK Investigational Site
Randwick, New South Wales, Australia
Start Date
February 19, 2014
Primary Completion Date
May 20, 2014
Completion Date
May 20, 2014
Last Updated
May 15, 2017
NCT06712563
NCT06831994
NCT02755974
NCT05087641
NCT05050591
NCT05913765
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions